TY - JOUR
T1 - Mesenchymal stem cells
T2 - Potential for therapy and treatment of chronic non-healing skin wounds
AU - Marfia, Giovanni
AU - Navone, Stefania Elena
AU - Di Vito, Clara
AU - Ughi, Nicola
AU - Tabano, Silvia
AU - Miozzo, Monica
AU - Tremolada, Carlo
AU - Bolla, Gianni
AU - Crotti, Chiara
AU - Ingegnoli, Francesca
AU - Rampini, Paolo
AU - Riboni, Laura
AU - Gualtierotti, Roberta
AU - Campanella, Rolando
PY - 2015/1/1
Y1 - 2015/1/1
N2 - Wound healing is a complex physiological process including overlapping phases (hemostatic/inflammatory, proliferating and remodeling phases). Every alteration in this mechanism might lead to pathological conditions of different medical relevance. Treatments for chronic nonhealing wounds are expensive because reiterative treatments are needed. Regenerative medicine and in particular mesenchymal stem cells approach is emerging as new potential clinical application in wound healing. In the past decades, advance in the understanding of molecular mechanisms underlying wound healing process has led to extensive topical administration of growth factors as part of wound care. Currently, no definitive treatment is available and the research on optimal wound care depends upon the efficacy and cost-benefit of emerging therapies. Here we provide an overview on the novel approaches through stem cell therapy to improve cutaneous wound healing, with a focus on diabetic wounds and Systemic Sclerosis-associated ulcers, which are particularly challenging. Current and future treatment approaches are discussed with an emphasis on recent advances.
AB - Wound healing is a complex physiological process including overlapping phases (hemostatic/inflammatory, proliferating and remodeling phases). Every alteration in this mechanism might lead to pathological conditions of different medical relevance. Treatments for chronic nonhealing wounds are expensive because reiterative treatments are needed. Regenerative medicine and in particular mesenchymal stem cells approach is emerging as new potential clinical application in wound healing. In the past decades, advance in the understanding of molecular mechanisms underlying wound healing process has led to extensive topical administration of growth factors as part of wound care. Currently, no definitive treatment is available and the research on optimal wound care depends upon the efficacy and cost-benefit of emerging therapies. Here we provide an overview on the novel approaches through stem cell therapy to improve cutaneous wound healing, with a focus on diabetic wounds and Systemic Sclerosis-associated ulcers, which are particularly challenging. Current and future treatment approaches are discussed with an emphasis on recent advances.
KW - Adipose stem cells
KW - Autoimmune diseases
KW - Diabetes
KW - Mesenchymal stem cells
KW - Systemic sclerosis
KW - Ulcer
KW - Wound
UR - http://www.scopus.com/inward/record.url?scp=84964294549&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84964294549&partnerID=8YFLogxK
U2 - 10.1080/15476278.2015.1126018
DO - 10.1080/15476278.2015.1126018
M3 - Article
AN - SCOPUS:84964294549
SN - 1547-6278
VL - 11
SP - 183
EP - 206
JO - Organogenesis
JF - Organogenesis
IS - 4
ER -